AONN+ Annual 2020
SAT13 - Product Theater 8 | Overview of Immune-Related Adverse Events Caused by Immune-Checkpoint Inhibitor’s Presentation by Bristol-Myers Squibb
Nov 7, 2020 3:15pm ‐ Nov 7, 2020 4:15pm
Ann L. Clark
, RN, MSN, CCRC, CCRP, Immuno-Oncology Clinical Liaison, BMS Oncology, US Medical
You must be logged in and own this session in order to post comments.
© 2021 Digitell, Inc. All Rights Reserved